Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.67 USD | +1.07% | +5.98% | -14.35% |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
Mar. 21 | Transcript : TELA Bio, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.35% | 140M | |
+3.26% | 197B | |
+5.79% | 116B | |
+1.48% | 71.49B | |
+11.77% | 53.47B | |
+18.31% | 48.42B | |
+6.33% | 43.64B | |
+12.38% | 28.97B | |
+9.76% | 28.47B | |
+10.35% | 27.78B |
- Stock
- Equities
- Stock TELA Bio, Inc. - Nasdaq
- News TELA Bio, Inc.
- TELA Bio Enters Into New $50 Million Credit Facility With MidCap Financial